Hepatitis B Virus Infection and Response to Antiretroviral Therapy (ART) in a South African ART Program

Abstract

We revealed that HBV status does not affect HIV RNA suppression, CD4 cell count response, or mortality during the first 72 weeks of HAART in an African setting. The risk of HBV-associated hepatotoxicity, however, is associated with the baseline HBV DNA level.